SAN DIEGO, April 03, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing, and care delivered in the home, today announced its home ...
(RTTNews) - ResMed Inc.(RMD), announced Thursday that its NightOwl home sleep apnea test or HSAT is now available across the United States, providing a simple and effective at-home diagnostic solution ...
ResMed Inc . (NYSE:RMD; ASX:RMD), a leading player in the sleep and respiratory care market, has demonstrated strong operational performance in recent quarters. However, the company faces potential ...
Resmed is making another strategic investment in U.S.-based manufacturing and distribution, this time in Indianapolis. The move aims to position the company’s inventory of CPAP devices ...
(MENAFN- GetNews) Air Voel, a trusted name in sleep therapy solutions and an official distributor of ResMed devices in Canada, is proud to introduce the ResMed AirSense 11 Auto, the latest advancement ...
TipRanks on MSN
ResMed’s Nyx3 Study: A New Frontier in Sleep Technology
Resmed Inc (($RMD)) announced an update on their ongoing clinical study. Study Overview: ResMed Inc. is conducting a study titled ‘Nyx3 Eye Mask ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback